Cleanup job
16 January 2019

Rakesh Kapoor will leave the Nurofen maker after eight years. The stock has soared in his tenure, but the exit comes after a series of mishaps, weak sales growth, and a controversial acquisition. The successor will also have to decide whether to proceed with a complex breakup.
This content is for Subscribers only
To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.